目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Formulation
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global doxorubicin market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global doxorubicin market 2017 - 2021 ($ million)
4.2 Formulation Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Formulation Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Formulation
6.1 Market segments
Exhibit 30: Chart on Formulation - Market share 2022-2027 (%)
Exhibit 31: Data Table on Formulation - Market share 2022-2027 (%)
6.2 Comparison by Formulation
Exhibit 32: Chart on Comparison by Formulation
Exhibit 33: Data Table on Comparison by Formulation
6.3 Lyophilized powder - Market size and forecast 2022-2027
Exhibit 34: Chart on Lyophilized powder - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Lyophilized powder - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Lyophilized powder - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Lyophilized powder - Year-over-year growth 2022-2027 (%)
6.4 Doxorubicin injection - Market size and forecast 2022-2027
Exhibit 38: Chart on Doxorubicin injection - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Doxorubicin injection - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Doxorubicin injection - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Doxorubicin injection - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Formulation
Exhibit 42: Market opportunity by Formulation ($ million)
Exhibit 43: Data Table on Market opportunity by Formulation ($ million)

7 Market Segmentation by End-user
7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacy - Market size and forecast 2022-2027
Exhibit 56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2022-2027 (%)
Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ million)
Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Baxter International Inc.
Exhibit 115: Baxter International Inc. - Overview
Exhibit 116: Baxter International Inc. - Business segments
Exhibit 117: Baxter International Inc. - Key news
Exhibit 118: Baxter International Inc. - Key offerings
Exhibit 119: Baxter International Inc. - Segment focus
12.4 Cipla Ltd.
Exhibit 120: Cipla Ltd. - Overview
Exhibit 121: Cipla Ltd. - Business segments
Exhibit 122: Cipla Ltd. - Key news
Exhibit 123: Cipla Ltd. - Key offerings
Exhibit 124: Cipla Ltd. - Segment focus
12.5 Dr Reddys Laboratories Ltd.
Exhibit 125: Dr Reddys Laboratories Ltd. - Overview
Exhibit 126: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 127: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 128: Dr Reddys Laboratories Ltd. - Segment focus
12.6 Hikma Pharmaceuticals Plc
Exhibit 129: Hikma Pharmaceuticals Plc - Overview
Exhibit 130: Hikma Pharmaceuticals Plc - Business segments
Exhibit 131: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 132: Hikma Pharmaceuticals Plc - Segment focus
12.7 Intas Pharmaceuticals Ltd.
Exhibit 133: Intas Pharmaceuticals Ltd. - Overview
Exhibit 134: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 135: Intas Pharmaceuticals Ltd. - Key offerings
12.8 Johnson and Johnson
Exhibit 136: Johnson and Johnson - Overview
Exhibit 137: Johnson and Johnson - Business segments
Exhibit 138: Johnson and Johnson - Key news
Exhibit 139: Johnson and Johnson - Key offerings
Exhibit 140: Johnson and Johnson - Segment focus
12.9 Meiji Holdings Co. Ltd.
Exhibit 141: Meiji Holdings Co. Ltd. - Overview
Exhibit 142: Meiji Holdings Co. Ltd. - Business segments
Exhibit 143: Meiji Holdings Co. Ltd. - Key news
Exhibit 144: Meiji Holdings Co. Ltd. - Key offerings
Exhibit 145: Meiji Holdings Co. Ltd. - Segment focus
12.10 Merck KGaA
Exhibit 146: Merck KGaA - Overview
Exhibit 147: Merck KGaA - Business segments
Exhibit 148: Merck KGaA - Key news
Exhibit 149: Merck KGaA - Key offerings
Exhibit 150: Merck KGaA - Segment focus
12.11 Novartis AG
Exhibit 151: Novartis AG - Overview
Exhibit 152: Novartis AG - Business segments
Exhibit 153: Novartis AG - Key offerings
Exhibit 154: Novartis AG - Segment focus
12.12 Pfizer Inc.
Exhibit 155: Pfizer Inc. - Overview
Exhibit 156: Pfizer Inc. - Product / Service
Exhibit 157: Pfizer Inc. - Key news
Exhibit 158: Pfizer Inc. - Key offerings
12.13 S. G. Biopharm Pvt. Ltd.
Exhibit 159: S. G. Biopharm Pvt. Ltd. - Overview
Exhibit 160: S. G. Biopharm Pvt. Ltd. - Product / Service
Exhibit 161: S. G. Biopharm Pvt. Ltd. - Key offerings
12.14 Sun Pharmaceutical Industries Ltd.
Exhibit 162: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 163: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 164: Sun Pharmaceutical Industries Ltd. - Key offerings
12.15 Synbias Pharma AG
Exhibit 165: Synbias Pharma AG - Overview
Exhibit 166: Synbias Pharma AG - Product / Service
Exhibit 167: Synbias Pharma AG - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 168: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 169: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 170: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 171: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 172: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Zydus Lifesciences Ltd.
Exhibit 173: Zydus Lifesciences Ltd. - Overview
Exhibit 174: Zydus Lifesciences Ltd. - Business segments
Exhibit 175: Zydus Lifesciences Ltd. - Key offerings
Exhibit 176: Zydus Lifesciences Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Formulation
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global doxorubicin market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Formulation Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Formulation - Market share 2022-2027 (%)
Exhibits31: Data Table on Formulation - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Formulation
Exhibits33: Data Table on Comparison by Formulation
Exhibits34: Chart on Lyophilized powder - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Lyophilized powder - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Lyophilized powder - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Lyophilized powder - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Doxorubicin injection - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Doxorubicin injection - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Doxorubicin injection - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Doxorubicin injection - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Formulation ($ million)
Exhibits43: Data Table on Market opportunity by Formulation ($ million)
Exhibits44: Chart on End-user - Market share 2022-2027 (%)
Exhibits45: Data Table on End-user - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by End-user
Exhibits47: Data Table on Comparison by End-user
Exhibits48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by End-user ($ million)
Exhibits65: Data Table on Market opportunity by End-user ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2022-2027 (%)
Exhibits68: Data Table on Market share by geography 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity by geography ($ million)
Exhibits108: Data Tables on Market opportunity by geography ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Baxter International Inc. - Overview
Exhibits116: Baxter International Inc. - Business segments
Exhibits117: Baxter International Inc. - Key news
Exhibits118: Baxter International Inc. - Key offerings
Exhibits119: Baxter International Inc. - Segment focus
Exhibits120: Cipla Ltd. - Overview
Exhibits121: Cipla Ltd. - Business segments
Exhibits122: Cipla Ltd. - Key news
Exhibits123: Cipla Ltd. - Key offerings
Exhibits124: Cipla Ltd. - Segment focus
Exhibits125: Dr Reddys Laboratories Ltd. - Overview
Exhibits126: Dr Reddys Laboratories Ltd. - Business segments
Exhibits127: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits128: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits129: Hikma Pharmaceuticals Plc - Overview
Exhibits130: Hikma Pharmaceuticals Plc - Business segments
Exhibits131: Hikma Pharmaceuticals Plc - Key offerings
Exhibits132: Hikma Pharmaceuticals Plc - Segment focus
Exhibits133: Intas Pharmaceuticals Ltd. - Overview
Exhibits134: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits135: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits136: Johnson and Johnson - Overview
Exhibits137: Johnson and Johnson - Business segments
Exhibits138: Johnson and Johnson - Key news
Exhibits139: Johnson and Johnson - Key offerings
Exhibits140: Johnson and Johnson - Segment focus
Exhibits141: Meiji Holdings Co. Ltd. - Overview
Exhibits142: Meiji Holdings Co. Ltd. - Business segments
Exhibits143: Meiji Holdings Co. Ltd. - Key news
Exhibits144: Meiji Holdings Co. Ltd. - Key offerings
Exhibits145: Meiji Holdings Co. Ltd. - Segment focus
Exhibits146: Merck KGaA - Overview
Exhibits147: Merck KGaA - Business segments
Exhibits148: Merck KGaA - Key news
Exhibits149: Merck KGaA - Key offerings
Exhibits150: Merck KGaA - Segment focus
Exhibits151: Novartis AG - Overview
Exhibits152: Novartis AG - Business segments
Exhibits153: Novartis AG - Key offerings
Exhibits154: Novartis AG - Segment focus
Exhibits155: Pfizer Inc. - Overview
Exhibits156: Pfizer Inc. - Product / Service
Exhibits157: Pfizer Inc. - Key news
Exhibits158: Pfizer Inc. - Key offerings
Exhibits159: S. G. Biopharm Pvt. Ltd. - Overview
Exhibits160: S. G. Biopharm Pvt. Ltd. - Product / Service
Exhibits161: S. G. Biopharm Pvt. Ltd. - Key offerings
Exhibits162: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits163: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits164: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits165: Synbias Pharma AG - Overview
Exhibits166: Synbias Pharma AG - Product / Service
Exhibits167: Synbias Pharma AG - Key offerings
Exhibits168: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits169: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits170: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits171: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits172: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits173: Zydus Lifesciences Ltd. - Overview
Exhibits174: Zydus Lifesciences Ltd. - Business segments
Exhibits175: Zydus Lifesciences Ltd. - Key offerings
Exhibits176: Zydus Lifesciences Ltd. - Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations